---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-024172"
form_type: "8-K"
ticker: "BIAF"
cik: "0001712762"
company_name: "bioAffinity Technologies, Inc."
filed_at: "2025-08-14T23:59:59+00:00"
generated_at: "2026-05-17T13:17:54.306649+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# bioAffinity closes $1.45M capital raise and reclassifies warrants adding $2.8M to equity

## Summary
- Private placement of 990 Series B Preferred shares convertible into ~4.3M common at $0.23/sh and warrants for ~6.7M shares at $0.352/sh, gross proceeds ~$1.2M.
- Warrant inducement: existing warrants exercised at reduced $0.23/sh for $253K cash; new warrants for 1.43M shares at $0.352/sh pending stockholder approval.
- Warrant amendment reclassifies May 2025 warrants from liability to equity, increasing stockholders' equity by ~$2.8M.
- Anti-dilution adjustment on May 2025 warrants reduces exercise price to $0.23/sh and increases shares issuable by ~8M.
- Authorized common shares increased from 100M to 350M.

## SEC filing metadata
- accession: 0001641172-25-024172
- form_type: 8-K
- ticker: BIAF
- cik: 0001712762
- company_name: bioAffinity Technologies, Inc.
- filed_at: 2025-08-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1712762/000164117225024172/0001641172-25-024172-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1712762/000164117225024172/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-024172
- JSON: https://secwatch.observer/filing/0001641172-25-024172.json
- Plain text: https://secwatch.observer/filing/0001641172-25-024172.txt

## Key facts
- Governance Changes
  bioAffinity Technologies, Inc.: Increased authorized shares of Common Stock from 100,000,000 to 350,000,000 and designated Series B Convertible Preferred Stock (effective 2025-08-13).
  - Change: charter amendment
  - Effective: 2025-08-13
  source text: On August 13, 2025, the Company filed a Certificate of Amendment to the Company’s Certificate of Incorporation (the “Certificate of Amendment”) to increase the number of authorized shares of the Company’s Common Stock from 100,000,000 to 350,000,000.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1712762/000164117225024172/0001641172-25-024172-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.